tiprankstipranks
Trending News
More News >
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
US Market
Advertisement

Aspen Pharmacare (APNHY) Income Statement

Compare
22 Followers

Aspen Pharmacare Income Statement

Last quarter (Q4 2023), Aspen Pharmacare's total revenue was Rs23.57B, an increase of 22.57% from the same quarter last year. In Q4, Aspen Pharmacare's net income was Rs2.09B. See Aspen Pharmacare’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
Rs 44.71BRs 40.71BRs 38.61BRs 37.77BRs 38.65B
Gross Profit
Rs 19.42BRs 18.41BRs 18.31BRs 17.79BRs 19.33B
Operating Expenses
Rs 12.42BRs 9.46BRs 9.47BRs 8.60BRs 10.37B
Depreciation and Amortization
Rs 1.97BRs 1.79BRs 1.71BRs 1.64BRs 1.55B
EBITDA
Rs 9.90BRs 9.50BRs 10.48BRs 8.67BRs 7.27B
Operating Income
Rs 7.00BRs 7.82BRs 8.67BRs 7.07BRs 7.06B
Other Income/Expenses
Rs -1.28BRs -1.27BRs -537.00MRs -1.08BRs -1.53B
Pretax Income
Rs 5.71BRs 6.55BRs 8.13BRs 5.99BRs 5.60B
Net Income
Rs 4.40BRs 5.23BRs 6.49BRs 4.81BRs 4.66B
Per Share Metrics
Basic EPS
Rs 9.91Rs 11.77Rs 14.32Rs 9.66Rs 10.64
Diluted EPS
Rs 9.91Rs 11.77Rs 14.32Rs 9.66Rs 10.64
Weighted Average Shares Outstanding
444.20M 444.20M 453.00M 456.50M 456.50M
Weighted Average Shares Outstanding (Diluted)
444.20M 444.20M 453.00M 456.50M 456.50M
Currency in ZAR

Aspen Pharmacare Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis